Product NDC: | 0093-9612 |
Proprietary Name: | Doxepin Hydrochloride |
Non Proprietary Name: | Doxepin Hydrochloride |
Active Ingredient(s): | 10 mg/mL & nbsp; Doxepin Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-9612 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA071609 |
Marketing Category: | ANDA |
Start Marketing Date: | 19871106 |
Package NDC: | 0093-9612-12 |
Package Description: | 120 mL in 1 BOTTLE, GLASS (0093-9612-12) |
NDC Code | 0093-9612-12 |
Proprietary Name | Doxepin Hydrochloride |
Package Description | 120 mL in 1 BOTTLE, GLASS (0093-9612-12) |
Product NDC | 0093-9612 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Doxepin Hydrochloride |
Dosage Form Name | SOLUTION, CONCENTRATE |
Route Name | ORAL |
Start Marketing Date | 19871106 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | DOXEPIN HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Tricyclic Antidepressant [EPC] |